SSA
Schonfeld Strategic Advisors Portfolio holdings
AUM
$13.3B
1-Year Return
26.83%
This Quarter Return
+10.92%
1 Year Return
+26.83%
3 Year Return
+97.05%
5 Year Return
+189.63%
10 Year Return
–
AUM
$4.98B
AUM Growth
+$1.36B
(+38%)
Cap. Flow
+$1.09B
Cap. Flow
% of AUM
21.89%
Top 10 Holdings %
Top 10 Hldgs %
15.08%
Holding
1,759
New
587
Increased
426
Reduced
256
Closed
471
Top Buys
| 1 |
Amazon
AMZN
|
+$104M |
| 2 |
Scotiabank
BNS
|
+$82M |
| 3 |
Johnson Controls International
JCI
|
+$42.9M |
| 4 |
TC Energy
TRP
|
+$40.9M |
| 5 |
Canadian Imperial Bank of Commerce
CM
|
+$40M |
Top Sells
| 1 |
Tesla
TSLA
|
+$85.5M |
| 2 |
Alibaba
BABA
|
+$45.5M |
| 3 |
Fidelity National Information Services
FIS
|
+$36.7M |
| 4 |
Gaotu Techedu
GOTU
|
+$30.9M |
| 5 |
IPHI
INPHI CORPORATION
IPHI
|
+$25.5M |
Sector Composition
| 1 | Technology | 18.14% |
| 2 | Financials | 15.92% |
| 3 | Consumer Discretionary | 14.29% |
| 4 | Healthcare | 10.03% |
| 5 | Industrials | 9.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
526
Ross Stores
ROST
$49.6B
| $1.67M | 0.03% |
17,892
-5,718
| -24% | -$534K |
|
527
VeriSign
VRSN
$26.4B
| $1.67M | 0.03% |
8,154
-37,381
| -82% | -$7.66M |
|
528
Labcorp
LH
$23B
| $1.67M | 0.03% |
10,303
-10,991
| -52% | -$1.78M |
|
|
ALXN
529
DELISTED
Alexion Pharmaceuticals Inc
ALXN
| $1.64M | 0.03% |
14,367
-10,174
| -41% | -$1.16M |
|
530
Corsair Gaming
CRSR
$944M
| $1.64M | 0.03% |
+81,709
| New | +$1.64M |
|
531
Charles River Laboratories
CRL
$7.97B
| $1.64M | 0.03% |
+7,251
| New | +$1.64M |
|
532
Hewlett Packard
HPE
$31.5B
| $1.64M | 0.03% |
+175,030
| New | +$1.64M |
|
533
Kirby Corp
KEX
$4.98B
| $1.64M | 0.03% |
+45,264
| New | +$1.64M |
|
534
Acadia Pharmaceuticals
ACAD
$4.28B
| $1.64M | 0.03% |
39,629
+16,676
| +73% | +$688K |
|
535
Boeing
BA
$174B
| $1.63M | 0.03% |
+9,888
| New | +$1.63M |
|
|
OTIC
536
DELISTED
Otonomy, Inc.
OTIC
| $1.62M | 0.03% |
399,087
+229,116
| +135% | +$928K |
|
537
ITT
ITT
$13.5B
| $1.61M | 0.03% |
27,297
-137,324
| -83% | -$8.11M |
|
538
Gentex
GNTX
$6.3B
| $1.61M | 0.03% |
62,564
+17,761
| +40% | +$457K |
|
539
SiriusXM
SIRI
$8.17B
| $1.6M | 0.03% |
29,750
-35,119
| -54% | -$1.88M |
|
|
RDHL
540
Redhill Biopharma
RDHL
$3.26M
| $1.59M | 0.03% |
155
+55
| +55% | +$563K |
|
541
Vertex Pharmaceuticals
VRTX
$101B
| $1.59M | 0.03% |
5,827
+1,160
| +25% | +$316K |
|
542
Immunovant
IMVT
$2.86B
| $1.58M | 0.03% |
44,912
+10,512
| +31% | +$370K |
|
543
Darling Ingredients
DAR
$4.94B
| $1.57M | 0.03% |
+43,673
| New | +$1.57M |
|
544
nCino
NCNO
$3.52B
| $1.57M | 0.03% |
+19,709
| New | +$1.57M |
|
545
Cousins Properties
CUZ
$4.88B
| $1.57M | 0.03% |
54,828
-23,901
| -30% | -$684K |
|
546
Standard BioTools
LAB
$520M
| $1.56M | 0.03% |
+210,600
| New | +$1.56M |
|
|
CADE
547
DELISTED
Cadence Bancorporation
CADE
| $1.56M | 0.03% |
181,900
+104,596
| +135% | +$899K |
|
548
PJT Partners
PJT
$4.41B
| $1.56M | 0.03% |
25,758
-182,246
| -88% | -$11M |
|
|
CLVS
549
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.56M | 0.03% |
+267,646
| New | +$1.56M |
|
550
Skillz
SKLZ
$115M
| $1.55M | 0.03% |
+6,387
| New | +$1.55M |
|